Incidentaloma differential diagnosis: Difference between revisions
Line 113: | Line 113: | ||
=== Differential diagnosis of Cushing's disease from other diseases === | === Differential diagnosis of Cushing's disease from other diseases === | ||
The table below summarizes the findings that differentiate Cushing's disease from other conditions that may cause [[Hypertension|hypertensio]]<nowiki/>n, [[hyperandrogenism]], and [[obesity]]. Facial [[plethora]], [[skin changes]], [[osteoporosis]], [[nephrolithiasis]] and [[neuropsychiatric]] conditions should raise the concern for Cushing's syndrome.<ref name="pmid11253984">{{cite journal |vauthors=Boscaro M, Barzon L, Fallo F, Sonino N |title=Cushing's syndrome |journal=Lancet |volume=357 |issue=9258 |pages=783–91 |year=2001 |pmid=11253984 |doi=10.1016/S0140-6736(00)04172-6 |url=}}</ref><ref name="pmid11571938">{{cite journal |vauthors=Findling JW, Raff H |title=Diagnosis and differential diagnosis of Cushing's syndrome |journal=Endocrinol. Metab. Clin. North Am. |volume=30 |issue=3 |pages=729–47 |year=2001 |pmid=11571938 |doi= |url=}}</ref><ref name="pmid9793762">{{cite journal |vauthors=Newell-Price J, Trainer P, Besser M, Grossman A |title=The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states |journal=Endocr. Rev. |volume=19 |issue=5 |pages=647–72 |year=1998 |pmid=9793762 |doi=10.1210/edrv.19.5.0346 |url=}}</ref><ref name="urlHow Is Metabolic Syndrome Diagnosed? - NHLBI, NIH">{{cite web |url=https://www.nhlbi.nih.gov/health/health-topics/topics/ms/diagnosis |title=How Is Metabolic Syndrome Diagnosed? - NHLBI, NIH |format= |work= |accessdate=}}</ref> | The table below summarizes the findings that differentiate [[Cushing's disease]] from other conditions that may cause [[Hypertension|hypertensio]]<nowiki/>n, [[hyperandrogenism]], and [[obesity]]. Facial [[plethora]], [[skin changes]], [[osteoporosis]], [[nephrolithiasis]] and [[neuropsychiatric]] conditions should raise the concern for [[Cushing's syndrome]].<ref name="pmid11253984">{{cite journal |vauthors=Boscaro M, Barzon L, Fallo F, Sonino N |title=Cushing's syndrome |journal=Lancet |volume=357 |issue=9258 |pages=783–91 |year=2001 |pmid=11253984 |doi=10.1016/S0140-6736(00)04172-6 |url=}}</ref><ref name="pmid11571938">{{cite journal |vauthors=Findling JW, Raff H |title=Diagnosis and differential diagnosis of Cushing's syndrome |journal=Endocrinol. Metab. Clin. North Am. |volume=30 |issue=3 |pages=729–47 |year=2001 |pmid=11571938 |doi= |url=}}</ref><ref name="pmid9793762">{{cite journal |vauthors=Newell-Price J, Trainer P, Besser M, Grossman A |title=The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states |journal=Endocr. Rev. |volume=19 |issue=5 |pages=647–72 |year=1998 |pmid=9793762 |doi=10.1210/edrv.19.5.0346 |url=}}</ref><ref name="urlHow Is Metabolic Syndrome Diagnosed? - NHLBI, NIH">{{cite web |url=https://www.nhlbi.nih.gov/health/health-topics/topics/ms/diagnosis |title=How Is Metabolic Syndrome Diagnosed? - NHLBI, NIH |format= |work= |accessdate=}}</ref> | ||
<br> | <br> | ||
{| align="center" | {| align="center" | ||
Line 142: | Line 142: | ||
*[[Kidney stone|Kidney stones]] | *[[Kidney stone|Kidney stones]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*24-hour urine cortisol | *24-hour urine [[cortisol]] | ||
*Midnight salivary cortisol | *Midnight salivary [[cortisol]] | ||
*[[Dexamethasone Oral|Low dose dexamethasone]] challenge test | *[[Dexamethasone Oral|Low dose dexamethasone]] challenge test | ||
*[[CRH]] stimulation | *[[CRH]] stimulation | ||
*[[Dexamethasone Oral|High dose dexamethasone]] test | *[[Dexamethasone Oral|High dose dexamethasone]] test | ||
*[[MRI|MRI brain]] | *[[MRI|MRI brain]] | ||
*CT/MRI adrenals | *[[Computed tomography|CT]]/[[Magnetic resonance imaging|MRI]] adrenals | ||
|- | |- | ||
Line 164: | Line 164: | ||
*[[Oligomenorrhea]]/[[hypogonadism]] | *[[Oligomenorrhea]]/[[hypogonadism]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Urinary free cortisol | *[[Urinary system|Urinary]] free [[cortisol]] | ||
*Midnight salivary cortisol | *Midnight salivary [[cortisol]] | ||
*Low dose dexamethasone challenge test | *Low dose [[dexamethasone]] challenge test | ||
*[[Glucose tolerance test]] | *[[Glucose tolerance test]] | ||
*Loperamide test | *[[Loperamide]] test | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" |[[Metabolic syndrome X]] | | style="background:#DCDCDC;" align="center" |[[Metabolic syndrome X]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Familial/genetic | *[[Family|Familial]]/[[Genetics|genetic]] | ||
*Obesity | *[[Obesity]] | ||
*Insulin resistance | *[[Insulin]] resistance | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Obesity]] | * [[Obesity]] | ||
Line 200: | Line 200: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" | [[Pheochromocytoma]] | | style="background:#DCDCDC;" align="center" | [[Pheochromocytoma]] | ||
|The symptoms of a pheochromocytoma are those of [[sympathetic nervous system]]<nowiki/>hyperactivity and include:<sup>[[Renal artery stenosis ultrasound#cite note-pmid23457117-1|[1]]]</sup> | |The symptoms of a [[pheochromocytoma]] are those of [[sympathetic nervous system]]<nowiki/>hyperactivity and include:<sup>[[Renal artery stenosis ultrasound#cite note-pmid23457117-1|[1]]]</sup> | ||
* [[Palpitations]] (especially in [[epinephrine]] producing tumors) | * [[Palpitations]] (especially in [[epinephrine]] producing tumors) | ||
* [[Anxiety]] | * [[Anxiety]] | ||
Line 214: | Line 214: | ||
* '''High-risk patients''': | * '''High-risk patients''': | ||
** [[Plasma]] fractionated [[Metanephrine|metanephrines]] | ** [[Plasma]] fractionated [[Metanephrine|metanephrines]] | ||
** 24-hour [[urinary]] fractionated [[Metanephrine|metanephrines]], catecholamines | ** 24-hour [[urinary]] fractionated [[Metanephrine|metanephrines]], [[Catecholamine|catecholamines]] | ||
** Imaging studies ([[CT scan]], [[Magnetic resonance imaging|MRI]] and iodine-123-meta-iodobenzylguanidine or MIBG scintiscan)<sup>[[Renal artery stenosis ultrasound#cite note-pmid23457117-1|[1]]]</sup> | ** Imaging studies ([[CT scan]], [[Magnetic resonance imaging|MRI]] and iodine-123-meta-iodobenzylguanidine or MIBG scintiscan)<sup>[[Renal artery stenosis ultrasound#cite note-pmid23457117-1|[1]]]</sup> | ||
Line 265: | Line 265: | ||
|Elevated [[blood pressure]], [[tachycardia]], and may be [[anxiety]] in a clinical setting but not in other settings<sup>[[Chronic hypertension differential diagnosis#cite note-pmid24107724-1|[1]]]</sup> | |Elevated [[blood pressure]], [[tachycardia]], and may be [[anxiety]] in a clinical setting but not in other settings<sup>[[Chronic hypertension differential diagnosis#cite note-pmid24107724-1|[1]]]</sup> | ||
| | | | ||
* Ambulatory blood pressure monitoring and patient self-measurement using a home [[blood pressure]] monitoring device are being increasingly used to differentiate patients with [[white coat hypertension]] from patients with true [[hypertension]]. | * Ambulatory [[blood pressure]] monitoring and patient self-measurement using a home [[blood pressure]] monitoring device are being increasingly used to differentiate patients with [[white coat hypertension]] from patients with true [[hypertension]]. | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" | [[Hyperthyroidism]] | | style="background:#DCDCDC;" align="center" | [[Hyperthyroidism]] | ||
Line 283: | Line 283: | ||
* [[Systolic hypertension]]<ref name="pmid2045465">{{cite journal| author=Mintz G, Pizzarello R, Klein I| title=Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. | journal=J Clin Endocrinol Metab | year= 1991 | volume= 73 | issue= 1 | pages= 146-50 | pmid=2045465 | doi=10.1210/jcem-73-1-146 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2045465 }}</ref> | * [[Systolic hypertension]]<ref name="pmid2045465">{{cite journal| author=Mintz G, Pizzarello R, Klein I| title=Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. | journal=J Clin Endocrinol Metab | year= 1991 | volume= 73 | issue= 1 | pages= 146-50 | pmid=2045465 | doi=10.1210/jcem-73-1-146 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2045465 }}</ref> | ||
| | | | ||
* Low [[thyroid-stimulating hormone]] (TSH) | * Low [[thyroid-stimulating hormone]] ([[Thyroid-stimulating hormone|TSH]]) | ||
* High [[Thyroxine|free thyroxine]] (T4) concentration | * High [[Thyroxine|free thyroxine]] ([[T4]]) concentration | ||
* High [[triiodothyronine]] (T3) concentration | * High [[triiodothyronine]] ([[Triiodothyronine|T3]]) concentration | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" | [[Renal artery stenosis|Renovascular hypertension]] | | style="background:#DCDCDC;" align="center" | [[Renal artery stenosis|Renovascular hypertension]] | ||
Line 304: | Line 304: | ||
| style="background:#DCDCDC;" align="center" | [[Stroke]] and [[Lateral medullary syndrome|compression of lateral medulla]] ([[Lateral medullary syndrome]]) | | style="background:#DCDCDC;" align="center" | [[Stroke]] and [[Lateral medullary syndrome|compression of lateral medulla]] ([[Lateral medullary syndrome]]) | ||
| | | | ||
* Extensive unilateral infarction of the [[brain stem]] in the region of the [[nucleus tractus solitarius]] may result in partial [[Baroreflex|baroreflex dysfunction]], increased sympathetic activity, and | * Extensive unilateral infarction of the [[brain stem]] in the region of the [[nucleus tractus solitarius]] may result in partial [[Baroreflex|baroreflex dysfunction]], increased sympathetic activity, and [[neurogenic]] [[paroxysmal hypertension]]. | ||
* [[Blurred vision]] or [[diplopia]] | * [[Blurred vision]] or [[diplopia]] | ||
* Weakness of [[Bulbar palsy|bulbar muscles]] | * Weakness of [[Bulbar palsy|bulbar muscles]] | ||
Line 315: | Line 315: | ||
* Ipsilateral decreased pain and temperature sensation in the face | * Ipsilateral decreased pain and temperature sensation in the face | ||
* The [[corneal reflex]] is usually reduced in the [[ipsilateral]] eye | * The [[corneal reflex]] is usually reduced in the [[ipsilateral]] eye | ||
* Contralateral loss of pain and thermal sensation involving the body and limbs | * Contralateral loss of [[pain]] and thermal sensation involving the body and limbs | ||
| | | | ||
* [[Computed tomography|CT]] shows mass compressing [[Lateral medullary syndrome|lateral medulla]] or infarction in the same area | * [[Computed tomography|CT]] shows mass compressing [[Lateral medullary syndrome|lateral medulla]] or infarction in the same area | ||
Line 323: | Line 323: | ||
* [[Tonic-clonic seizure]]: | * [[Tonic-clonic seizure]]: | ||
** Repetitive twitches of arm and legs | ** Repetitive twitches of arm and legs | ||
** Tongue bitting | ** [[Tongue]] bitting | ||
** [[Loss of consciousness]] | ** [[Loss of consciousness]] | ||
** Symptoms occur suddenly and may persist | ** Symptoms occur suddenly and may persist | ||
Line 342: | Line 342: | ||
* Physical examination is important when [[central nervous system infection]] or hemorrhage are diagnostic possibilities | * Physical examination is important when [[central nervous system infection]] or hemorrhage are diagnostic possibilities | ||
* A tongue bite or laceration in [[Tonic-clonic seizure|generalized tonic-clonic seizure]]<ref name="pmid23041172">{{cite journal|author=Brigo F, Storti M, Lochner P, Tezzon F, Fiaschi A, Bongiovanni LG et al.|title=Tongue biting in epileptic seizures and psychogenic events: an evidence-based perspective.|journal=Epilepsy Behav|year=2012|volume=25|issue=2|pages=251-5|pmid=23041172|doi=10.1016/j.yebeh.2012.06.020|pmc=|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23041172}}</ref> | * A [[tongue]] bite or laceration in [[Tonic-clonic seizure|generalized tonic-clonic seizure]]<ref name="pmid23041172">{{cite journal|author=Brigo F, Storti M, Lochner P, Tezzon F, Fiaschi A, Bongiovanni LG et al.|title=Tongue biting in epileptic seizures and psychogenic events: an evidence-based perspective.|journal=Epilepsy Behav|year=2012|volume=25|issue=2|pages=251-5|pmid=23041172|doi=10.1016/j.yebeh.2012.06.020|pmc=|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23041172}}</ref> | ||
| | | | ||
* Abnormal [[electroencephalography]]: a positive test without a clinical presentation is called a [[Subclinical seizure|sub-clinical seizure]].<ref name="pmid21205698">{{cite journal|author=Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT, American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association-Convened Physician Consortium for Performance Improvement Independent Measure Development Process|title=Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.|journal=Neurology|year=2011|volume=76|issue=1|pages=94-9|pmid=21205698|doi=10.1212/WNL.0b013e318203e9d1|pmc=|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21205698}}</ref> | * Abnormal [[electroencephalography]]: a positive test without a clinical presentation is called a [[Subclinical seizure|sub-clinical seizure]].<ref name="pmid21205698">{{cite journal|author=Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT, American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association-Convened Physician Consortium for Performance Improvement Independent Measure Development Process|title=Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.|journal=Neurology|year=2011|volume=76|issue=1|pages=94-9|pmid=21205698|doi=10.1212/WNL.0b013e318203e9d1|pmc=|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21205698}}</ref> | ||
* [[Lumbar puncture]] is useful to exclude acute [[central nervous system infections]]. | * [[Lumbar puncture]] is useful to exclude acute [[central nervous system infections]]. | ||
* A | * A neuro-imaging study should be performed in all adults with a first [[seizure]] to evaluate structural [[brain]] abnormalities. [[Magnetic resonance imaging]] is preferred over [[computed tomography]]. | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" |[[Carcinoid syndrome]] | | style="background:#DCDCDC;" align="center" |[[Carcinoid syndrome]] | ||
|[[Hypertensive crisis]] occurs with [[malignant carcinoid syndrome]]<ref name="pmid7969229">{{cite journal| author=Warner RR, Mani S, Profeta J, Grunstein E| title=Octreotide treatment of carcinoid hypertensive crisis. | journal=Mt Sinai J Med | year= 1994 | volume= 61 | issue= 4 | pages= 349-55 | pmid=7969229 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7969229 }}</ref>. Symptoms include: | |[[Hypertensive crisis]] occurs with [[malignant carcinoid syndrome]]<ref name="pmid7969229">{{cite journal| author=Warner RR, Mani S, Profeta J, Grunstein E| title=Octreotide treatment of carcinoid hypertensive crisis. | journal=Mt Sinai J Med | year= 1994 | volume= 61 | issue= 4 | pages= 349-55 | pmid=7969229 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7969229 }}</ref>. | ||
Symptoms include: | |||
* Severe [[chest]] pain | * Severe [[chest]] pain | ||
* Severe [[headache]] | * Severe [[headache]] | ||
Line 397: | Line 398: | ||
** Poor [[coordination]] | ** Poor [[coordination]] | ||
** [[Focal neurologic signs]] | ** [[Focal neurologic signs]] | ||
** [[Headache]]<nowiki/>s awakening the patient at | ** [[Headache]]<nowiki/>s awakening the patient at night<sup>[[Migraine CT#cite note-3|[3]]][[Migraine CT#cite note-4|[4]]]</sup> | ||
* Atypical [[aura]] | * Atypical [[aura]] | ||
* Sudden onset | * Sudden onset |
Revision as of 15:40, 7 November 2017
Incidentaloma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Incidentaloma differential diagnosis On the Web |
American Roentgen Ray Society Images of Incidentaloma differential diagnosis |
Risk calculators and risk factors for Incidentaloma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview
Adrenal incidentaloma must be differentiated from other diseases that cause adrenal masses such as adrenal adenoma, adrenocortical carcinoma, Cushing's syndrome, pheochromocytoma, and metastasis.
Differentiating different causese of Incidentaloma
- The cause of adrenal incidentaloma commonly include adrenal adenoma, sub-clinical Cushing's syndrome, pheochromocytoma, and adrenocortical carcinoma. These causes can be differentiated from each other as follows:
Differential Diagnosis | Clinical picture | Imagings | Laboratory tests | |
---|---|---|---|---|
Adrenal adenoma |
|
|
| |
Adrenocortical carcinoma |
|
|
| |
Cushing's syndrome |
|
|
| |
Pheochromocytoma |
|
|
| |
Adrenal metastasis |
|
|
Differential diagnosis of Cushing's disease from other diseases
The table below summarizes the findings that differentiate Cushing's disease from other conditions that may cause hypertension, hyperandrogenism, and obesity. Facial plethora, skin changes, osteoporosis, nephrolithiasis and neuropsychiatric conditions should raise the concern for Cushing's syndrome.[1][2][3][4]
Differentiating pheochromocytoma from other diseasesPheochromocytoma must be differentiated from other causes of paroxysmal hypertension. The differentials include:
References
|